Cormorant Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-153,975	Closed	-$4.2M	–	61
2017 Q2	$4.2M	Sell	153,975 -46,025	-23%	-$1.26M	0.7%	40
2017 Q1	$6.62M	Sell	200,000 -86,870	-30%	-$2.88M	0.96%	34
2016 Q4	$6.83M	Buy	286,870 +171,310	+148%	+$4.08M	0.92%	34
2016 Q3	$4.24M	Buy	+115,560	New	+$4.24M	0.47%	55